Introduction
As the body of scientific studies that describe or intervene on youth physical activity continues to expand, there is a growing need to be able to make comparisons across published studies, as well as synthesize the findings to inform policy-level decisions. One of the major limitations to synthesizing the youth physical activity literature is the numerous ways physical activity is measured. Objective measures of physical activity have largely been obtained using uniaxial accelerometers worn at the hip, (Stone, Faulkner, & Buliung, 2013; Troiano et al., 2008) but comparability between studies has been limited due to the large range of MVPA cut-points available for use with accelerometer data. (Bornstein et al., 2011; Brazendale et al., 2015) The advent of new technology and the growing popularity of the wrist wear-site only exacerbates the difficulties of comparing estimates of physical activity across studies.
The GENEActiv, ActiGraph GT3X+ and ActiGraph GT9X Link sample and store raw accelerations, rather than proprietary counts, and are designed for wrist-wear. The GENEActiv has grown in popularity as an objective measure of youth moderate-tovigorous physical activity (MVPA) since it was first introduced in 2008 and is most commonly used on the wrist. (Esliger et al., 2011) The ActiGraph GT3X+, worn on the wrist, has been used in NHANES since 2011, and while estimates of physical activity intensity from these wrist-worn accelerometers have demonstrated strong reliability and validity, (Esliger et al., 2011; Phillips, Parfitt, & Rowlands, 2013 ) the estimates of physical activity from wrist-worn devices cannot be directly compared to estimates of physical activity from hip-worn devices.
Two previous studies have addressed the issue of non-comparable estimates of physical activity across published studies through the development of conversion equations, referred to as the Rosetta Stone (Bornstein, et al., 2011; Brazendale, et al., 2015) . The equations convert estimates of MVPA from widely used cutpoints from a single hip-worn physical activity monitoring device (i.e., ActiGraph accelerometers). The application of these equations was illustrated in a subsequent study (Coelho et al. 2017) where published ActiGraph-derived estimates of MVPA for preschool-age children were "standardized" into a common cutpoint estimate of MVPA. This study illustrated that when applying the Rosetta Stone equations, differences in the estimates of MVPA across studies could be improved from ~80 minutes/day (range 11.6 to 219) to ~14 minutes/day (range 0.6 to 38.7). This reduced the differences in MVPA across studies due to the application of the varying cutpoints to distill ActiGraph data into minutes of MVPA.
In the absence of a comprehensive database containing all accelerometer-derived raw data files that could be standardized using a single data reduction procedure, the development of equating systems is necessary and should widely appeal to those seeking to synthesize the growing body of literature on youth physical activity. While progress has been made towards this effort, existing equating systems are limited to only a single hip-worn device -ActiGraph accelerometer. We are unaware of any equating systems that have been developed to compare estimates of MVPA across different wear-sites. A previous study (Rowlands et al., 2016) made comparisons among wrist-and hip-worn accelerometer-derived MVPA and found that, depending on the data reduction procedure, comparable estimates of minutes spent in MVPA could be obtained between the two placements. However, this study did not provide a way to standardize previously published group-level estimates of MVPA so numbers could be compared across different cut-points or placements. Therefore, the purpose of this study was to develop a series of Rosetta Stone conversion equations to compare estimates of MVPA derived from accelerations measured at the wrist and from ActiGraph counts measured at the hip in elementary school-aged children.
Methods
This is a secondary data analysis using data from three studies: 1) 58 children, aged 10-12 years, recruited from primary schools in South Australia (Rowlands et al., 2014) ; 2) 129 children, aged 9-10 years, recruited from primary schools in Liverpool, UK (Fairclough et al., 2016) ; 3) 81 children, aged 9-11 years, recruited from two primary schools in Liverpool, UK. The appropriate university research ethics committee approved each study. Written informed consent and assent were obtained from the parents/guardians and children, respectively. Height was measured to the nearest 0.1 cm and body mass to the nearest 0.1 kg.
Free-living physical activity was measured by concurrent wear of the GENEActiv on the non-dominant wrist and the ActiGraph GT3X+ positioned above the right hip, on a belt worn around the waist, for seven consecutive days. In study 1, children were requested to wear both monitors day and night, removing the hip-worn ActiGraph for water-based activities only. In studies 2 and 3, children were requested to wear both monitors at all times except when sleeping or during water-based activities.
The GENEActiv is a triaxial accelerometry-based activity monitor with a dynamic range of +/-8g (Gravity Estimator of Normal Everyday Activity, ActivInsights Ltd, Cambridgeshire, UK). The ActiGraph GT3X+ is a triaxial accelerometry-based activity monitor with a dynamic range of +/-6 g (ActiGraph LLC, Pensacola, FL, USA). Study 1:
The GENEActivs were initialized to collect data at 87.5 Hz and data uploaded using GENEActiv PC software version 2.2. The ActiGraphs were initialized to collect data at 80 Hz and data uploaded using Actilife version 6.5.3. Data were collected between April and December 2012. Studies 2 and 3: The GENEActivs and ActiGraphs were both initialized to collect data at 100 Hz and data uploaded using GENEActiv PC software version 2.2 and Actilife version 6.11.4, respectively. Study 2 data were collected between January and May 2014 and study 3 data were collected in January and February 2015. Study 1 captured data in 5 s epochs with studies 2 and 3 capturing data in 1 s epochs, thus, for study 1, ENMO was averaged over 5 s epochs; and for studies 2 and 3, ENMO was averaged over 1 s epochs.
Files were excluded from all analyses if post-calibration error was greater than 0.02 g and individual days were classified as invalid and excluded if wear-time was insufficient (16 h for the 24 h protocol in study 1, 10 h for the waking wear protocol in studies 2 and 3).
Detection of non-wear has been described in detail previously (See 'Procedure for nonwear detection' in supplementary document to van Hees et al., 2013 (van Hees, et al., 2013 ). In brief, non-wear is estimated based on the standard deviation and value range of each axis, calculated for 60 min windows with 15-min moving increments. If for at least 2 out of the 3 axes the SD is less than 13 mg or the value range is less than 50 mg the time window is classified as non-wear. The default non-wear setting was used, i.e. invalid data were imputed by the average at similar timepoints on different days of the week. The Consistent with established protocols, (Bornstein, et al., 2011; Brazendale, et al., 2015) linear and non-linear regression models were used to develop conversion equations in a and predicted MVPA estimates. (Bland & Altman, 1986) In the absence of an empirically derived range of acceptable error, ±10% was chosen and plotted to depict reasonable differences between actual and predicted MVPA values.
Results
A summary of the sample characteristics and estimates of MVPA across devices and cutpoints is presented in Table 1 GENEActiv to ActiGraph and ActiGraph to GENEActiv are presented in Table 2 .
Overall, the proportion of variation explained ranged from R 2 adj 0.52 to 0.56. This represented an absolute error in minutes ranging from 7.0 minutes/day up to 14.5 minutes/day or an absolute percent error ranging from 13.9% to 24.5%. The only models that included an additional independent explanatory variable were those converting GENEActiv with Pate ActiGraph cutpoints where age was included in the final models.
---Insert Table 1 and 2, and Supplemental Figure 1 here ---
The results from the 20-fold cross-validation are presented in Table 3 and Supplemental Figure 2 . The average absolute minute difference and absolute percent difference of the conversions for ActiGraph converted into GENEActiv estimates of MVPA demonstrated a high degree of comparability. Specifically, the average absolute differences in minutes ranged from 2.0 to 3.3 minutes/day, representing an average absolute percent error of 3.1% to 4.9%. Similar findings were observed when converting GENEActiv from ActiGraph, with the average absolute difference in minutes ranging from 1.1 to 9.0 minutes/day, representing an average absolute percent error ranging from 3.0% to 10.0%.
---Insert Table 3 and Supplemental Figure 2 here ---
Discussion
The purpose of this study was to develop conversion equations for comparing raw accelerations from wrist-worn GENEActiv and hip-worn ActiGraph derived estimates of MVPA across published studies. Overall, the equations developed demonstrated a high degree of accuracy when applied to the group-level means of the derivation sample. This suggests that those who wish to compare estimates of MVPA across published studies or wish to combine estimates of MVPA analytically across studies using different devices, for instance within a quantitative meta-analysis, can utilize the developed Rosetta Stone equations to standardize the estimates into a common metric of choice.
As the options for objective monitoring devices continue to diversify, this renders direct comparisons of the estimates of physical activity across studies as problematic. This problem has a long history in the field of physical activity, yet there are few solutions. (Kim, Beets, & Welk, 2012; S. Trost, 2007; Welk, McClain, & Ainsworth, 2012 ) Without a unifying consensus on the device and protocols for reducing activity intensity data, the field will continuously require some form of conversion procedures to facilitate direct comparisons across studies. The findings in this study provide evidence that, with a moderately high degree of accuracy, comparisons can be made across studies reporting group-level estimates of either the GENEActiv or ActiGraph accelerometer MVPA. This is important, especially as the use of the GENEActiv continues to increase, as well as, the expansion of the body of literature that has used or is currently using ActiGraph accelerometers.
There are several limitations that need attention. First, the sample for the development of equations while statistically appropriate in terms of size, may not be entirely representative of the estimates of GENEActiv and ActiGraph physical activity for youth aged 9 to 12 years. Also, the equations are only applicable to ActiGraph hip studies that have used 5 second epochs -the epochs used to generate the hip worn ActiGraph estimates of MVPA in this study. Thus, while the equations demonstrated a high degree of accuracy, additional equations may need to be developed to more accurately represent the "typical" activity levels of youth utilizing accelerations measured at the wrist and ActiGraph counts measured at the hip. Ideally, a larger and international dataset, like the International Children Accelerometry Database (ICAD) used in the past to develop Rosetta Stone equations, (Brazendale, et al., 2015) would be created that includes youth (≤18 years) simultaneously wearing two or more commonly used objective motion sensors. Further, the number of cutpoints evaluated herein does not represent the entirety of the cutpoints that exist and are used in the published literature. (Kim, et al., 2012) Thus, additional Rosetta Stone conversion equations are needed to convert all possible reduction methods. Lastly, similar to the cutpoints employed to develop past Rosetta Stone equations, (Bornstein, et al., 2011; Brazendale, et al., 2015) it must be noted that the cutpoints included in the present analysis were developed with some amount of error, and the prediction equations generated within this study bring an additional degree of error.
Despite this, the equations can be used to make comparisons more "similar" by standardizing them to a common metric, either MVPA derived from accelerations measured at the wrist or ActiGraph counts measured at the hip. This alone, should hold value to those seeking to compare activity levels from studies utilizing these two devices.
Conclusions
In conclusion, the developed equations demonstrate a high level of consistency among device-derived MVPA and the group-level converted estimates of MVPA. The authors recommend the use of these equations when comparing published estimates of MVPA using either device. Further, using the Rosetta Stone equations provides researchers and public-health professionals with a practical solution to synthesize findings that can aid with policy-level decisions regarding MVP 
